AT-3 Mouse Breast Cancer Cell Line

Introduction

The AT-3 mouse breast cancer cell line was established from a spontaneous mammary tumor arising in a transgenic MTAG mouse model. The MTAG mouse mammary tumor model recapitulates several key features of human breast cancer progression, including tumor development, invasion, and metastasis.

OriCell™ AT-3 Mouse Breast Cancer Cell Line can be used to establish syngeneic mouse breast cancer models for studying tumor biology, breast cancer progression, metastasis, and therapeutic responses.

When citing our products in academic publications, please use the following format: "OriCell™ [Product Name] + [Catalog Number], from Cyagen Biosciences."

Product Information

QC

• Pass the detection of bacteria, fungi, mycoplasma, and endotoxins.
• Verified by cell recovery viability testing.
• Verified by STR analysis.

Please refer to "COA" for details.

General Handling Principles

• Maintain strict aseptic technique. Ensure complete sterility throughout all procedures, particularly within the laminar flow hood and incubator.
• Follow standardized protocols. Adhere strictly to the product manual. Implement rigorous control over experimental variables and include appropriate parallel controls.
• Use high-quality consumables and reagents. This product requires culture vessels suitable for adherent growth, and the reuse of these vessels is not recommended. The reagents used must be validated for reliability, cell compatibility, and batch-to-batch consistency.

Warm Notice: The cryopreservation medium of this product contains DMSO, which may pose potential risks. Please handle it with care.